Renova Therapeutics, Inc. — Form D

Renova Therapeutics, Inc. of CARLSBAD, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-09. The offering totals $500K, of which $167K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-09-09
• Form: D
• Accession: 0002036392-24-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $500K
• Amount sold: $167K
• Remaining: $334K
• Investors: 7
• Date of first sale: 2024-07-23
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-523564

Issuer

• Name: Renova Therapeutics, Inc.
• CIK: 0002036392
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 701 PALOMAR AIRPORT ROAD, CARLSBAD, CA, 92011
• Phone: 8584611837

Officers, directors & promoters (8)

More

• CIK 2036392 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search